Acelrx Pharmaceuticals reported $390K in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Acelrx Pharmaceuticals ACRX:US $ 390K 77K
Acura Pharmaceuticals ACUR:US 87K 26K
Baxter International BAX:US $ 88M 40M
Becton, Dickinson and BDX:US $ 101M 3M
Johnson & Johnson JNJ:US $ 10M 50M
Pfizer PFE:US $ 322M 6M
Smiths SMIN:LN 24M 1000K
Teva Pharmaceutical TEVA:IT 238M 58M
Xeris Pharmaceuticals Inc XERS:US $ 3.52M 1.72M